company background image
SANO logo

Sanofi WBAG:SANO Stock Report

Last Price

€87.41

Market Cap

€109.4b

7D

-1.0%

1Y

-3.7%

Updated

20 Mar, 2024

Data

Company Financials +

SANO Stock Overview

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

SANO fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends5/6

Sanofi Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sanofi
Historical stock prices
Current Share Price€87.41
52 Week High€103.62
52 Week Low€81.55
Beta0.44
1 Month Change0.82%
3 Month Change-1.00%
1 Year Change-3.66%
3 Year Change6.61%
5 Year Change12.40%
Change since IPO2.75%

Recent News & Updates

Recent updates

Shareholder Returns

SANOAT PharmaceuticalsAT Market
7D-1.0%-1.7%1.0%
1Y-3.7%15.7%3.4%

Return vs Industry: SANO underperformed the Austrian Pharmaceuticals industry which returned 15.6% over the past year.

Return vs Market: SANO underperformed the Austrian Market which returned 2.2% over the past year.

Price Volatility

Is SANO's price volatile compared to industry and market?
SANO volatility
SANO Average Weekly Movement2.2%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement3.2%
10% most volatile stocks in AT Market4.7%
10% least volatile stocks in AT Market1.7%

Stable Share Price: SANO has not had significant price volatility in the past 3 months.

Volatility Over Time: SANO's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197386,088Paul Hudsonhttps://www.sanofi.com

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

Sanofi Fundamentals Summary

How do Sanofi's earnings and revenue compare to its market cap?
SANO fundamental statistics
Market cap€109.42b
Earnings (TTM)€5.40b
Revenue (TTM)€46.03b

20.3x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SANO income statement (TTM)
Revenue€46.03b
Cost of Revenue€14.22b
Gross Profit€31.82b
Other Expenses€26.42b
Earnings€5.40b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)4.32
Gross Margin69.12%
Net Profit Margin11.73%
Debt/Equity Ratio22.0%

How did SANO perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

87%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.